Haoxi Health Technology Ltd (HAO) — Institutional Holders, Q2 2026
3 institutional investment managers reported a HAO position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $62.3K. Every filer is listed below, ranked by position value. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.
HAO in Q2 2026: what funds did
Funds that filed a 13F for both Q1 2026 and Q2 2026, by what they did with the common stock. Share counts are adjusted for any split between the two quarters; dollar figures are the change in shares at this quarter’s price.
Biggest buyers
- Marex Group plcNew · +38,075 sh+$39.2K
- Virtu FinancialNew · +11,619 sh+$12.0K
- XTX Topco LtdAdded · +10,584 sh+$10.9K
Biggest sellers
- UBS Group AGSold out · -4 sh-$4.00
HAO 13F holders ranked 1–3 of 3
| # | Institution | Shares | Value | % of portfolio | QoQShares vs Q1 2026 |
|---|---|---|---|---|---|
| 1 | Marex Group plc#1 · 38,075 sh | 38,075 | $39.2K | <0.01% | New |
| 2 | Virtu Financial#2 · 11,619 sh | 11,619 | $12.0K | <0.01% | New |
| 3 | XTX Topco Ltd#3 · 10,734 sh | 10,734 | $11.1K | <0.01% | -44.0% |
Funds that sold out of HAO in Q2 2026 (1)
Held HAO at the end of Q1 2026 and filed a Q2 2026 13F without it. Not in the list above, because they no longer hold it. Largest prior position first.
| Institution | Shares sold | Value in Q1 2026 |
|---|---|---|
| UBS Group AG4 sh | 4 | $468.00 |
Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.